ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ertiprotafib. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2021-08-30

Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from Rhododendron capitatum.

Liang C, Kjaerulff L, Hansen PR, Kongstad KT, Staerk D.

J Nat Prod · journal article · DOI 10.1021/acs.jnatprod.1c00454

Bibliografisk träff 2020-04-07

PTP1B-Inhibiting Branched-Chain Fatty Acid Dimers from Eremophila oppositifolia subsp. angustifolia Identified by High-Resolution PTP1B Inhibition Profiling and HPLC-PDA-HRMS-SPE-NMR Analysis.

Pedersen HA, Ndi C, Semple SJ, Buirchell B, Møller BL, Staerk D.

J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jnatprod.0c00070

Bibliografisk träff 2016-05-28

Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.

Meng G, Zheng M, Wang M, Tong J, Ge W, Zhang J, Zheng A, Li J, Gao L, Li J.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2016.05.060

Bibliografisk träff 2015-04-04

Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Tautz L, Senis YA, Oury C, Rahmouni S.

Bioorg Med Chem · research support, non-u.s. gov't; research-article; review; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmc.2015.03.075

Bibliografisk träff 2011-12-01

Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition.

Otake K, Azukizawa S, Fukui M, Kunishiro K, Kamemoto H, Kanda M, Miike T, Kasai M, Shirahase H.

Bioorg Med Chem · journal article · DOI 10.1016/j.bmc.2011.11.035

Bibliografisk träff 2011-03-02

Using small molecules to target protein phosphatases.

Vintonyak VV, Waldmann H, Rauh D.

Bioorg Med Chem · journal article · DOI 10.1016/j.bmc.2011.02.047

Bibliografisk träff 2009-09-10

Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.

Bhattarai BR, Kafle B, Hwang JS, Khadka D, Lee SM, Kang JS, Ham SW, Han IO, Park H, Cho H.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2009.09.020

Bibliografisk träff 2009-02-20

Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.

Park H, Bhattarai BR, Ham SW, Cho H.

Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2009.02.011

Bibliografisk träff 2007-08-15

2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity.

Bhattarai BR, Shrestha S, Ham SW, Kim KR, Cheon HG, Lee KH, Cho H.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2007.08.019

Bibliografisk träff 2007-03-03

Methylenedisalicylic acid derivatives: new PTP1B inhibitors that confer resistance to diet-induced obesity.

Shrestha S, Bhattarai BR, Chang KJ, Lee KH, Cho H.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2007.02.069

Bibliografisk träff 2007-03-03

PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta).

Shrestha S, Bhattarai BR, Cho H, Choi JK, Cho H.

Bioorg Med Chem Lett · clinical trial, phase ii; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2007.03.001

Bibliografisk träff 2004-08-01

Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.

Hooft van Huijsduijnen R, Sauer WH, Sauer WH, Bombrun A, Swinnen D.

J Med Chem · review; journal article · DOI 10.1021/jm030629n

Gå till forskningen.

Publikationer i urvalet

Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from <i>Rhododendron capitatum</i>.

PTP1B-Inhibiting Branched-Chain Fatty Acid Dimers from <i>Eremophila oppositifolia</i> subsp. <i>angustifolia</i> Identified by High-Resolution PTP1B Inhibition Profiling and HPLC-PDA-HRMS-SPE-NMR Analysis.

Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.

Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition.

Using small molecules to target protein phosphatases.

Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.

Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.

2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity.

Methylenedisalicylic acid derivatives: new PTP1B inhibitors that confer resistance to diet-induced obesity.

PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta).

Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.